Mohammad Azab

Companies

• Caladrius BiosciencesBoard member Sep 16, 2022 to now¹
• DURECT CORPBoard member Jan 5, 2021 to now²
• Xenon PharmaceuticalsBoard member Nov 4, 2014 to Dec 20, 2023³
• Astex PharmaceuticalsChief Medical Officer Jul 23, 2009 to Oct 16, 2013⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• XPXenon Pharmaceuticals XENE74,225 shares⁵$2.6M at $34.78Dec 19, 2023
• CBCaladrius Biosciences LSTA104,925 shares⁶$112.3K at $1.07Jan 9, 2026
• DDURECT CORP0 shares⁷Sep 11, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 9, 2026Granted 30,456 shares of Caladrius Biosciences⁶
• Sep 11, 2025U 6,000 shares of DURECT CORP⁷
• Jan 9, 2025Granted 15,789 shares of Caladrius Biosciences⁸
• Jan 9, 2024Granted 19,480 shares of Caladrius Biosciences⁹
• Dec 19, 2023Exercised options 3,497 shares at $9.85 of Xenon Pharmaceuticals⁵
• Dec 19, 2023Exercised options 823 shares at $9.85 of Xenon Pharmaceuticals⁵
• Jan 9, 2023Granted 20,000 shares of Caladrius Biosciences¹⁰
• Dec 12, 2022Exercised options 3,086 shares at $2.68 of Xenon Pharmaceuticals¹¹
• Sep 15, 2022Granted 19,200 shares at $6.25 of Caladrius Biosciences¹²
• May 24, 2022Bought 5,000 shares at $0.39 of DURECT CORP¹³
• May 24, 2022Bought 10,000 shares at $0.39 of DURECT CORP¹³
• May 24, 2022Bought 5,000 shares at $0.38 of DURECT CORP¹³
• May 24, 2022Bought 5,000 shares at $0.39 of DURECT CORP¹³
• May 24, 2022Bought 5,000 shares at $0.39 of DURECT CORP¹³
• May 17, 2022Bought 1,800 shares at $0.42 of DURECT CORP¹⁴
• May 17, 2022Bought 8,900 shares at $0.42 of DURECT CORP¹⁴
• May 17, 2022Bought 9,300 shares at $0.42 of DURECT CORP¹⁴
• May 16, 2022Bought 10,000 shares at $0.38 of DURECT CORP¹⁴
• Dec 15, 2021Exercised options 3,086 shares at $3.67 of Xenon Pharmaceuticals¹⁵